Evaluating the effectiveness of evidence-based guidelines for the use of spacer devices in children with acute asthma

M Gazarian1, R L Henry, S R Wales

  • 1School of Women's and Children's Health, Sydney Children's Hospital, NSW.

Insights

This study successfully transitioned pediatric asthma treatment from nebulizers to metered dose inhalers with spacers, demonstrating no change in hospitalization rates or duration. This shift in acute asthma care improved bronchodilator delivery in children.

Area of Science:

  • Pediatric Emergency Medicine
  • Respiratory Medicine
  • Clinical Practice Change

Background:

  • Acute asthma exacerbations in children often require bronchodilator therapy.
  • Nebulizers have been the traditional delivery method, but metered dose inhalers with spacers offer potential advantages.

Purpose of the Study:

  • To evaluate the implementation of a practice change from nebulizers to metered dose inhalers and holding chambers (spacers) for children with mild to moderate acute asthma.
  • To assess the impact of this change on clinical outcomes, including hospitalization and length of stay.

Main Methods:

  • A before-and-after study comparing children with acute asthma presenting to a tertiary care children's hospital emergency department.
  • Intervention involved developing evidence-based guidelines for spacer use and implementing a multifaceted guideline program.
  • Data collected on physician prescribing practices and clinical outcomes (hospitalization, ICU admission, length of stay).

Main Results:

  • The proportion of children treated with spacers in the emergency department increased from 0% in 1997 to 94% in 1999.
  • Hospital admission rates remained similar between the two periods (29% vs. 30%).
  • The median length of stay for children with asthma was comparable in both study years (1.7 days).

Conclusions:

  • Standard practice for bronchodilator delivery in mild to moderate acute asthma in children was successfully shifted from nebulizers to spacers.
  • This change in practice was achieved without adversely affecting the need for hospitalization or its duration.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...